PO.CL01.14 · 临床研究

利用G4X™空间测序仪对FFPE切片中RNA、蛋白和形态学进行整合式高通量多模态空间分析

Integrated high-throughput multimodal spatial profiling of RNA, protein, and morphology in FFPE sections with the G4X™ Spatial Sequencer

海报缩略图:利用G4X™空间测序仪对FFPE切片中RNA、蛋白和形态学进行整合式高通量多模态空间分析
编号 6685 展板 27 时间 4/21 02:00–05:00 区域 Section 48 主讲 Michael Lawson, PhD
分会场 Spatial Proteomics and Transcriptomics 3
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Michael Lawson1, Kenneth Gouin1, Sabrina Shore2, Yuji Ishitsuka2, Richard Que2, Eli Glezer2, Daan Witters2

1Singular Genomics, San Diego, CA,2Singular Genomics, LA JOLLA, CA

摘要 Abstract

中文摘要
对肿瘤微环境(TME)的全面表征受益于在临床相关样本中以单细胞分辨率同时测量转录本、蛋白和形态学。G4X空间测序仪是一个高通量的原位平台,可从同一FFPE切片中提供共配准的RNA、蛋白和形态学读出,每次运行支持多达40 cm²的组织,并具备灵活的panel定制能力。我们为肾脏、肺、结肠和乳腺组织设计了四个靶向的约300基因RNA panel。每个panel包含150个共享的免疫肿瘤学基因、50个基质基因和约100个组织特异性靶标。配套的16重免疫肿瘤学蛋白panel提供了空间分辨的多重蛋白质组学测量。所有分析物均从单张5 µm切片中获取,并与fH&E™(标准H&E的荧光类似物)直接对齐。 切片通过TissuStamp™转移工作流程,以大型(每流动池10个10 × 10 mm²)或小型(每流动池32个4.5 × 4.5 mm²)阵列进行处理,经过抗体染色、挂锁探针杂交、扩增和合成测序(SBS)。每个细胞的检测范围为50-200个转录本和20-50个独特基因,在高表达细胞中动态范围超过500个转录本。RNA假发现率≤0.5%(通常<0.1%),基因组DNA的FDR为0.5-5%,且转录本检测不受同步蛋白成像的影响。 蛋白数据质量与单重免疫荧光相当,将蛋白丰度与基因表达程序整合,其跨模态特异性超越了单基因比较。 除了针对转录本和蛋白的精选panel外,G4X还支持纳入自定义靶标。基于测序的读出保留了探针水平的分辨率,能够在不丢失信息的情况下高效优化自定义RNA panel,这一点已在小鼠、骨髓和胰腺数据集中得到验证。两个额外的自定义蛋白靶标被成功纳入精选的16重panel。 为凸显其可扩展性,G4X已部署于与学术合作伙伴正在进行的图谱规模肺癌和结直肠癌研究中,并已用于跨系列切片的三维重建。 综上所述,这些结果确立了G4X作为一个统一、可扩展的工作流程,用于对FFPE组织进行多重空间转录组学、蛋白质组学和形态学分析,从而实现对TME的大队列、整合性分析。
查看英文原文 English abstract
Comprehensive characterization of the tumor microenvironment (TME) benefits from simultaneous measurement of transcripts, proteins, and morphology at single-cell resolution in clinically relevant samples. The G4X Spatial Sequencer is a high-throughput in-situ platform that delivers co-registered RNA, protein, and morphological readouts from the same FFPE section, supporting up to 40 cm² of tissue per run and flexible panel customization. We designed four targeted ~300-gene RNA panels for kidney, lung, colon, and breast tissues. Each includes 150 shared immuno-oncology genes, 50 stromal genes, and ~100 tissue-specific targets. A paired 16-plex immuno-oncology protein panel provides spatially resolved multiplexed proteomics measurements. All analytes were acquired from single 5 µm sections and directly aligned with fH&E™, a fluorescent analog of standard H&E. Sections were processed via the TissuStamp™ transfer workflow in large (ten 10 × 10 mm²/flow cell) or small (thirty two 4.5 × 4.5 mm²/flow cell) arrays through antibody staining, padlock probe hybridization, amplification, and sequencing-by-synthesis (SBS). Per-cell detection ranged from 50-200 transcripts and 20-50 unique genes, with dynamic ranges exceeding 500 transcripts in high-expressing cells. RNA false discovery rates were ≤0.5% (typically <0.1%), and genomic DNA FDRs were 0.5-5%, with transcript detection unaffected by concurrent protein imaging. Protein data quality matched single-plex immunofluorescence, and integration of protein abundance with gene-expression programs improved cross-modal specificity beyond single-gene comparisons. In addition to curated panels for transcripts and proteins, G4X enables the inclusion of custom targets. The sequencing-based readout preserves probe-level resolution, enabling efficient optimization of custom RNA panels without loss of information, demonstrated across mouse, bone marrow, and pancreas datasets. Two additional custom protein targets were successfully incorporated into the curated 16-plex panel. To highlight scalability, G4X is deployed in ongoing atlas-scale lung and colorectal cancer studies with academic partners and has been used for 3D reconstruction across serial sections. Together, these results position G4X as a unified, scalable workflow for multiplexed spatial transcriptomic, proteomic, and morphological profiling of FFPE tissues, enabling large-cohort, integrative analyses of the TME.
利益披露 Disclosure
M. Lawson, None.

← 返回 AACR 2026 检索